Patents by Inventor Charles Friedman

Charles Friedman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210337902
    Abstract: A method of making a face shield using a bar tack stitch to join a face shield lens to a backing. The backing may be a headband or the combination of the headband and a cushion. The lens and the optional cushion may be joined together and then the lens may be stitched to the cushion and the headband. A bar tack stitch may be used to join the backing and lens together. Stitching the lens to its backing produces a novel face shield with high quality structural integrity that can be made quickly and cost effectively to eliminate limitations associated with bonded face shield lenses and removable joined face shield lenses.
    Type: Application
    Filed: April 30, 2020
    Publication date: November 4, 2021
    Applicant: Lifethereal LLC
    Inventor: Charles Friedman
  • Patent number: 11122798
    Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.
    Type: Grant
    Filed: March 16, 2020
    Date of Patent: September 21, 2021
    Assignee: Monsanto Technology LLC
    Inventors: Wenjin Deng, Todd Charles Friedman, John W. Hemminghaus, Liwei Yuan, Junhua Zhang
  • Publication number: 20200281196
    Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.
    Type: Application
    Filed: March 16, 2020
    Publication date: September 10, 2020
    Applicant: Monsanto Technology LLC
    Inventors: Wenjin Deng, Todd Charles Friedman, John W. Hemminghaus, Liwei Yuan, Junhua Zhang
  • Patent number: 10638751
    Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.
    Type: Grant
    Filed: January 6, 2016
    Date of Patent: May 5, 2020
    Assignee: Monsanto Technology LLC
    Inventors: Junhua Zhang, John W. Hemminghaus, Todd Charles Friedman, Wenjin Deng, Liwei Yuan
  • Publication number: 20160192645
    Abstract: Aqueous pesticidal mixtures comprising a microencapsulated pesticide and an agent that modulates the release rate of the pesticide from the microcapsules are described. Also described are various methods of modulating the release rate of a microencapsulated pesticide in a pesticidal mixture. Further, various pesticidal mixtures comprising a microencapsulated pesticide and a co-pesticide that provides for enhanced crop safety are described.
    Type: Application
    Filed: January 6, 2016
    Publication date: July 7, 2016
    Applicant: Monsanto Technology LLC
    Inventors: Junhua Zhang, John W. Hemminghaus, Todd Charles Friedman, Wenjin Deng, Liwei Yuan
  • Publication number: 20160136148
    Abstract: The invention relates to solid dispersions containing paroxetine mesylate. One solid dispersion contains amorphous paroxetine mesylate and a methacrylic acid-methyl methacrylate copolymer, where the weight ratio of paroxetine mesylate to polymer ranges from about 30:70 to about 90:10. Another solid dispersion contains amorphous paroxetine mesylate and a-vinylpyrrolidone/vinylacetate copolymer (PVP-VA), where the weight ratio of paroxetine mesylate to copolymer ranges from about 30:70 to about 50:50. An amorphous solid dispersion of the invention may have a single glass transition temperature. An amorphous solid dispersion is stable for at least 48 hours at 60° C. and 75% relative humidity. A further embodiment of the invention relates to pharmaceutical compositions of paroxetine mesylate comprising a solid dispersion of the invention and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: November 10, 2015
    Publication date: May 19, 2016
    Applicant: NOVEN THERAPEUTICS, LLC
    Inventors: David A. Engers, Yonglai Yang, Stephen Parent, Travis Houston, Bruce Charles Friedman
  • Patent number: 9211290
    Abstract: The invention relates to solid dispersions containing paroxetine mesylate. One solid dispersion contains amorphous paroxetine mesylate and a methacrylic acid-methyl methacrylate copolymer, where the weight ratio of paroxetine mesylate to polymer ranges from about 30:70 to about 90:10. Another solid dispersion contains amorphous paroxetine mesylate and a -vinylpyrrolidone/vinylacetate copolymer (PVP-VA), where the weight ratio of paroxetine mesylate to copolymer ranges from about 30:70 to about 50:50. An amorphous solid dispersion of the invention may have a single glass transition temperature. An amorphous solid dispersion is stable for at least 48 hours at 60° C. and 75% relative humidity. A further embodiment of the invention relates to pharmaceutical compositions of paroxetine mesylate comprising a solid dispersion of the invention and at least one pharmaceutically acceptable excipient.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: December 15, 2015
    Assignee: NOVEN THERAPEUTICS, LLC
    Inventors: David A. Engers, Yonglai Yang, Stephan Parent, Travis Houston, Bruce Charles Friedman
  • Publication number: 20140187582
    Abstract: The invention relates to solid dispersions containing paroxetine mesylate. One solid dispersion contains amorphous paroxetine mesylate and a methacrylic acid-methyl methacrylate copolymer, where the weight ratio of paroxetine mesylate to polymer ranges from about 30:70 to about 90:10. Another solid dispersion contains amorphous paroxetine mesylate and a -vinylpyrrolidone/vinylacetate copolymer (PVP-VA), where the weight ratio of paroxetine mesylate to copolymer ranges from about 30:70 to about 50:50. An amorphous solid dispersion of the invention may have a single glass transition temperature. An amorphous solid dispersion is stable for at least 48 hours at 60° C. and 75% relative humidity. A further embodiment of the invention relates to pharmaceutical compositions of paroxetine mesylate comprising a solid dispersion of the invention and at least one pharmaceutically acceptable excipient.
    Type: Application
    Filed: March 15, 2013
    Publication date: July 3, 2014
    Inventors: David A. ENGERS, Yonglai YANG, Stephan PARENT, Travis HOUSTON, Bruce Charles FRIEDMAN
  • Publication number: 20110125230
    Abstract: A light therapy device includes a first module adapted to be coupled to a head of an individual, and a second module including at least one light, the second module being coupled to the first module so that the second module is positioned relative to the individual's eyes, and the second module powering the light to provide indirect light therapy to the individual.
    Type: Application
    Filed: November 23, 2009
    Publication date: May 26, 2011
    Inventors: Ronald Charles Friedman, Kingman P. Strohl, Phyllis C. Zee
  • Publication number: 20060025108
    Abstract: Mobile communications devices display contextually relevant information based on the presence, status, and identification of a user. Lens templates control how the information is displayed and can be customized and designed for specific usage profiles. The lenses that are used can be updated at any time to accommodate changes in a user's presence. The granularity of the lenses and corresponding information can also vary to accommodate different needs and preferences. Lenses can also be specialized for different events or venues. The lenses allow a user to access contextually relevant information from a mobile communications device having limited display and/or browse capabilities without requiring a user to navigate through undesired information, wasting valuable resources in the process.
    Type: Application
    Filed: September 15, 2005
    Publication date: February 2, 2006
    Applicant: Microsoft Corporation
    Inventors: Mike Pell, Charles Friedman
  • Publication number: 20060019716
    Abstract: Mobile communications devices display contextually relevant information based on the presence, status, and identification of a user. Lens templates control how the information is displayed and can be customized and designed for specific usage profiles. The lenses that are used can be updated at any time to accommodate changes in a user's presence. The granularity of the lenses and corresponding information can also vary to accommodate different needs and preferences. Lenses can also be specialized for different events or venues. The lenses allow a user to access contextually relevant information from a mobile communications device having limited display and/or browse capabilities without requiring a user to navigate through undesired information, wasting valuable resources in the process.
    Type: Application
    Filed: September 15, 2005
    Publication date: January 26, 2006
    Applicant: Microsoft Corporation
    Inventors: Mike Pell, Charles Friedman